Relapses in multiple sclerosis: Relationship to disability

Douglas S. Goodin, Anthony T. Reder, Robert A. Bermel, Gary R. Cutter, Robert J. Fox, Gareth R. John, Fred D. Lublin, Claudia F Lucchinetti, Aaron E. Miller, Daniel Pelletier, Michael K. Racke, Bruce D. Trapp, Timothy Vartanian, Emmanuelle Waubant

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a recurrent inflammatory disease of the central nervous system, which ultimately causes substantial disability in many patients. A key clinical feature of this disease is the occurrence of relapses, consisting of episodes of neurological dysfunction followed by periods of remission. This review considers in detail the importance of the occurrence of relapses to the ultimate course of MS and the impact of relap setreatment (both acutely and prophylactically) on the long-term outcome for individuals. The ultimate goal of therapy in MS is the reduction of long-term disability. Clinical trials in MS, however, typically only extend for a very short time period compared to the time it takes for disability to evolve. Consequently, short-term outcome measures that are associated with, and predict, future disability need to be identified. In this regard, not only are relapses a characteristic feature of MS, they have also been proven to be associated with the occurrence of long-term disability. Moreover, treatments that reduce the number and severity of these attacks improve the long-term prognosis.

Original languageEnglish (US)
Pages (from-to)10-20
Number of pages11
JournalMultiple Sclerosis and Related Disorders
Volume6
DOIs
StatePublished - Mar 1 2016

Fingerprint

Multiple Sclerosis
Recurrence
Central Nervous System Diseases
Outcome Assessment (Health Care)
Clinical Trials
Therapeutics

Keywords

  • Disability
  • Lesion
  • MRI
  • Multiple sclerosis
  • Relapse
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Goodin, D. S., Reder, A. T., Bermel, R. A., Cutter, G. R., Fox, R. J., John, G. R., ... Waubant, E. (2016). Relapses in multiple sclerosis: Relationship to disability. Multiple Sclerosis and Related Disorders, 6, 10-20. https://doi.org/10.1016/j.msard.2015.09.002

Relapses in multiple sclerosis : Relationship to disability. / Goodin, Douglas S.; Reder, Anthony T.; Bermel, Robert A.; Cutter, Gary R.; Fox, Robert J.; John, Gareth R.; Lublin, Fred D.; Lucchinetti, Claudia F; Miller, Aaron E.; Pelletier, Daniel; Racke, Michael K.; Trapp, Bruce D.; Vartanian, Timothy; Waubant, Emmanuelle.

In: Multiple Sclerosis and Related Disorders, Vol. 6, 01.03.2016, p. 10-20.

Research output: Contribution to journalArticle

Goodin, DS, Reder, AT, Bermel, RA, Cutter, GR, Fox, RJ, John, GR, Lublin, FD, Lucchinetti, CF, Miller, AE, Pelletier, D, Racke, MK, Trapp, BD, Vartanian, T & Waubant, E 2016, 'Relapses in multiple sclerosis: Relationship to disability', Multiple Sclerosis and Related Disorders, vol. 6, pp. 10-20. https://doi.org/10.1016/j.msard.2015.09.002
Goodin, Douglas S. ; Reder, Anthony T. ; Bermel, Robert A. ; Cutter, Gary R. ; Fox, Robert J. ; John, Gareth R. ; Lublin, Fred D. ; Lucchinetti, Claudia F ; Miller, Aaron E. ; Pelletier, Daniel ; Racke, Michael K. ; Trapp, Bruce D. ; Vartanian, Timothy ; Waubant, Emmanuelle. / Relapses in multiple sclerosis : Relationship to disability. In: Multiple Sclerosis and Related Disorders. 2016 ; Vol. 6. pp. 10-20.
@article{b24803c666474239930bb85696fa6422,
title = "Relapses in multiple sclerosis: Relationship to disability",
abstract = "Multiple sclerosis (MS) is a recurrent inflammatory disease of the central nervous system, which ultimately causes substantial disability in many patients. A key clinical feature of this disease is the occurrence of relapses, consisting of episodes of neurological dysfunction followed by periods of remission. This review considers in detail the importance of the occurrence of relapses to the ultimate course of MS and the impact of relap setreatment (both acutely and prophylactically) on the long-term outcome for individuals. The ultimate goal of therapy in MS is the reduction of long-term disability. Clinical trials in MS, however, typically only extend for a very short time period compared to the time it takes for disability to evolve. Consequently, short-term outcome measures that are associated with, and predict, future disability need to be identified. In this regard, not only are relapses a characteristic feature of MS, they have also been proven to be associated with the occurrence of long-term disability. Moreover, treatments that reduce the number and severity of these attacks improve the long-term prognosis.",
keywords = "Disability, Lesion, MRI, Multiple sclerosis, Relapse, Treatment",
author = "Goodin, {Douglas S.} and Reder, {Anthony T.} and Bermel, {Robert A.} and Cutter, {Gary R.} and Fox, {Robert J.} and John, {Gareth R.} and Lublin, {Fred D.} and Lucchinetti, {Claudia F} and Miller, {Aaron E.} and Daniel Pelletier and Racke, {Michael K.} and Trapp, {Bruce D.} and Timothy Vartanian and Emmanuelle Waubant",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.msard.2015.09.002",
language = "English (US)",
volume = "6",
pages = "10--20",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
publisher = "Elsevier",

}

TY - JOUR

T1 - Relapses in multiple sclerosis

T2 - Relationship to disability

AU - Goodin, Douglas S.

AU - Reder, Anthony T.

AU - Bermel, Robert A.

AU - Cutter, Gary R.

AU - Fox, Robert J.

AU - John, Gareth R.

AU - Lublin, Fred D.

AU - Lucchinetti, Claudia F

AU - Miller, Aaron E.

AU - Pelletier, Daniel

AU - Racke, Michael K.

AU - Trapp, Bruce D.

AU - Vartanian, Timothy

AU - Waubant, Emmanuelle

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Multiple sclerosis (MS) is a recurrent inflammatory disease of the central nervous system, which ultimately causes substantial disability in many patients. A key clinical feature of this disease is the occurrence of relapses, consisting of episodes of neurological dysfunction followed by periods of remission. This review considers in detail the importance of the occurrence of relapses to the ultimate course of MS and the impact of relap setreatment (both acutely and prophylactically) on the long-term outcome for individuals. The ultimate goal of therapy in MS is the reduction of long-term disability. Clinical trials in MS, however, typically only extend for a very short time period compared to the time it takes for disability to evolve. Consequently, short-term outcome measures that are associated with, and predict, future disability need to be identified. In this regard, not only are relapses a characteristic feature of MS, they have also been proven to be associated with the occurrence of long-term disability. Moreover, treatments that reduce the number and severity of these attacks improve the long-term prognosis.

AB - Multiple sclerosis (MS) is a recurrent inflammatory disease of the central nervous system, which ultimately causes substantial disability in many patients. A key clinical feature of this disease is the occurrence of relapses, consisting of episodes of neurological dysfunction followed by periods of remission. This review considers in detail the importance of the occurrence of relapses to the ultimate course of MS and the impact of relap setreatment (both acutely and prophylactically) on the long-term outcome for individuals. The ultimate goal of therapy in MS is the reduction of long-term disability. Clinical trials in MS, however, typically only extend for a very short time period compared to the time it takes for disability to evolve. Consequently, short-term outcome measures that are associated with, and predict, future disability need to be identified. In this regard, not only are relapses a characteristic feature of MS, they have also been proven to be associated with the occurrence of long-term disability. Moreover, treatments that reduce the number and severity of these attacks improve the long-term prognosis.

KW - Disability

KW - Lesion

KW - MRI

KW - Multiple sclerosis

KW - Relapse

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84961249133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961249133&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2015.09.002

DO - 10.1016/j.msard.2015.09.002

M3 - Article

C2 - 27063617

AN - SCOPUS:84961249133

VL - 6

SP - 10

EP - 20

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

SN - 2211-0348

ER -